Bioproduction and Bioprocessing

We help labs change the world.

We create robust, powerful electroporation and electrofusion instruments that help labs develop and produce novel drugs and vaccines. Our BTX ECM 2001+ and 2001 Lite are ideal for monoclonal antibody (mAB) development, and our AgilePulse™ Max is ideal for vaccine production. BTX equipment has been used to develop some of the world’s leading therapies, including mAB treatments for Covid-19.

Why BTX?

BTX offers advanced electroporation solutions for fast, efficient transfection with cuvette and chamber sizes ranging from 80μL to 10ml. Specifically engineered for large-volume applications, our AgilePulse MAX system maximizes cellular uptake with minimal heating and a short cycle time to ensure high cell viability.

And we take cell viability seriously at BTX – in fact, in one peer-reviewed study, our ECM 830 was found to offer a 96% rate of cell viability and a 97.3% rate of transfection efficiency – the highest performer among 5 other well-known instruments.

Ready to learn more?

We´re here to help. Contact us for questions or quoting information